Epigenetics and migraine complex mitochondrial interactions contributing to disease susceptibility

Gene

Volumn 543, Issue 1, 2014, Pages 1-7

  Roos Araujo, Deidré ^a   Stuart, Shani ^a   Lea, Rod A ^a   Haupt, Larisa M ^a   Griffiths, Lyn R ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Disease susceptibility; Epigenetics; Migraine; Mitochondrial methylation

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA; UNTRANSLATED RNA;

AEROBIC METABOLISM; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC VARIABILITY; GENOME IMPRINTING; HERITABILITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; MIGRAINE; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MYOPATHY; OXIDATIVE PHOSPHORYLATION; PATHOGENICITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SUMOYLATION; TRANSCRIPTION INITIATION;

DISEASE SUSCEPTIBILITY; EPIGENETICS; MIGRAINE; MITOCHONDRIAL METHYLATION;

EPIGENESIS, GENETIC; EPISTASIS, GENETIC; GENES, MITOCHONDRIAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; HUMANS; INHERITANCE PATTERNS; MIGRAINE DISORDERS; MITOCHONDRIA;

EID: 84899647287     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.04.001     Document Type: Review

References (84)

1. Akerman S., Holland P.R., Goadsby P.J. Diencephalic and brainstem mechanisms in migraine. Nature Reviews. Neuroscience 2011, 12(10):570-584.
2. Anamika K., et al. Lessons from genome-wide studies: an integrated definition of the coactivator function of histone acetyl transferases. Epigenetics & Chromatin 2010, 3(1):18.
3. Bandiera S., et al. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 2011, 6(6):e20746.
4. Bird A. Perceptions of epigenetics. Nature 2007, 447(7143):396-398.
5. Boekema E.J., Braun H.P. Supramolecular structure of the mitochondrial oxidative phosphorylation system. The Journal of Biological Chemistry 2007, 282(1):1-4.
6. Brown M.D., et al. Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations. Human Mutation 1995, 6(4):311-325.
7. Carninci P. Tagging mammalian transcription complexity. Trends in Genetics 2006, 22(9):501-510.
8. Carrozza M.J., et al. The diverse functions of histone acetyltransferase complexes. Trends in Genetics 2003, 19(6):321-329.
9. Chestnut B.A., et al. Epigenetic regulation of motor neuron cell death through DNA methylation. Journal of Neuroscience 2011, 31(46):16619-16636.
10. Chomyn A., et al. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. The Journal of Biological Chemistry 2000, 275(25):19198-19209.
11. Coskun P., et al. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochimica et Biophysica Acta 2012, 1820(5):553-564.
12. Cotter D., et al. MitoProteome: mitochondrial protein sequence database and annotation system. Nucleic Acids Research 2004, 32:D463-D467. (Database issue).
13. de Almeida R.F., et al. Migraine with persistent visual aura: response to furosemide. Clinics 2009, 64(4):375-376.
14. Dehan P., et al. DNA methylation and cancer diagnosis: new methods and applications. Expert Review of Molecular Diagnostics 2009, 9(7):651-657.
15. DiMauro S., et al. Mitochondrial myopathies. Annals of Neurology 1985, 17(6):521-538.
16. Egensperger R., et al. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathology and Applied Neurobiology 1997, 23(4):315-321.
17. Egger G., et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429(6990):457-463.
18. Eising E., et al. Epigenetic mechanisms in migraine: a promising avenue?. BMC Medicine 2013, 11:26.
19. Elson J.L., et al. Associating mitochondrial DNA variation with complex traits. American Journal of Human Genetics 2007, 80(2):378-382. (author reply 382-3).
20. Eriksen M.K., Thomsen L.L., Olesen J. New international classification of migraine with aura (ICHD-2) applied to 362 migraine patients. European Journal of Neurology 2004, 11(9):583-591.
21. Geetha R.V.A.R. Mitochondrial DNA and inherited diseases a comprehensive review. Drug Invention Today 2011, 3(9).
22. Goadsby P.J., Akerman S. The trigeminovascular system does not require a peripheral sensory input to be activated - migraine is a central disorder focus on 'effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system'. Cephalalgia: an international journal of headache 2012, 32(1):3-5.
23. Guan M.X. Molecular pathogenetic mechanism of maternally inherited deafness. Mitochondrial Pathogenesis: From Genes and Apoptosis to Aging and Disease 2004, 1011:259-271.
24. Gustavsson A., et al. Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology 2011, 21(10):718-779.
25. Hammans S.R., et al. The mitochondrial-DNA transfer RNA(Lys) a→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged-red fibers (MERRF) - relationship of clinical phenotype to proportion of mutant mitochondrial-DNA. Brain: A Journal of Neurology 1993, 116:617-632.
26. Hanna M.G., et al. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. Journal of Neurology, Neurosurgery, and Psychiatry 1998, 65(4):512-517.
27. Hao H.L., Moraes C.T. Functional and molecular mitochondrial abnormalities associated with a C→T transition at position 3256 of the human mitochondrial genome - the effects of a pathogenic mitochondrial tRNA point mutation in organelle translation and RNA processing. Journal of Biological Chemistry 1996, 271(4):2347-2352.
28. Hayashi J.I., et al. Accumulation of mtDNA with a mutation at position-3271 in transfer RNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa-cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory-function. Biochemical and Biophysical Research Communications 1993, 197(3):1049-1055.
29. Hill W.G., Mackay T.F., Falconer D.S. Introduction to quantitative genetics. Genetics 2004, 167(4):1529-1536.
30. Ho T.W., Edvinsson L., Goadsby P.J. CGRP and its receptors provide new insights into migraine pathophysiology. Nature Reviews. Neurology 2010, 6(10):573-582.
31. Honkasalo M.L., et al. Migraine and concomitant symptoms among 8167 adult twin-pairs. Headache 1995, 35(2):70-78.
32. Iacobazzi V., et al. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Molecular Genetics and Metabolism 2013, 110(1-2):25-34.
33. Infantino V., et al. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Molecular Genetics and Metabolism 2011, 102(3):378-382.
34. Ino H., et al. Mitochondrial leucine tRNA mutation in a mitochondrial encephalomyopathy. Lancet 1991, 337(8735):234-235.
35. Issa J.P., et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 2004, 103(5):1635-1640.
36. Ito M., et al. Screening for mitochondrial, DNA heteroplasmy in children at risk for mitochondrial disease. Mitochondrion 2001, 1(3):269-278.
37. Jones P.A., Taylor S.M. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980, 20(1):85-93.
38. Klein G. Epigenetics: surveillance team against cancer. Nature 2005, 434(7030):150.
39. Kobayashi Y., et al. The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic-acidosis and stroke-like episodes (MELAS) were selectively amplified through generations. Journal of Inherited Metabolic Disease 1992, 15(5):803-808.
40. Laird P.W. The power and the promise of DNA methylation markers. Nature Reviews. Cancer 2003, 3(4):253-266.
41. Lambert G.A., Truong L., Zagami A.S. Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system. Cephalalgia: An International Journal of Headache 2011, 31(14):1439-1451.
42. Leonardi M., et al. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). Journal of Headache and Pain 2005, 6(6):429-440.
43. Lestienne P., Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1988, 1(8590):885.
44. Macgregor S., et al. Bias, precision and heritability of self-reported and clinically measured height in Australian twins. Human Genetics 2006, 120(4):571-580.
45. Marks P.A., Miller T., Richon V.M. Histone deacetylases. Current Opinion in Pharmacology 2003, 3(4):344-351.
46. Melone M.A.B., et al. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. Archives of Neurology 2004, 61(2):269-272.
47. Mulder E.J., et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Research: The Official Journal of the International Society for Twin Studies 2003, 6(5):422-431.
48. Nandakumar V., Vaid M., Katiyar S.K. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32(4):537-544.
49. Neupert W. Protein import into mitochondria. Annual Review of Biochemistry 1997, 66(1):863-917.
50. Nishigaki Y., et al. Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations. Mitochondrion 2010, 10(3):300-308.
51. Nyholt D.R., et al. Evidence for an X-linked genetic component in familial typical migraine. Human Molecular Genetics 1998, 7(3):459-463.
52. Olesen J., Lipton R.B. Migraine classification and diagnosis. International Headache Society criteria. Neurology 1994, 44(6 Suppl. 4):S6-S10.
53. Oshinsky M.L., Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache 2006, 46(Suppl. 1):S39-S44.
54. Ozawa M., et al. Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle & Nerve 1997, 20(3):271-278.
55. Papageorgiou E.A., et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nature Medicine 2011, 17(4):510-513.
56. Passaro D., et al. Epigenetic chromatin modifications in the cortical spreading depression. Brain Research 2010, 1329:1-9.
57. Qureshi I.A., Mehler M.F. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiology of Disease 2010, 39(1):53-60.
58. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenetics and Cell Genetics 1975, 14(1):9-25.
59. Riggs A.D. X chromosome inactivation, differentiation, and DNA methylation revisited, with a tribute to Susumu Ohno. Cytogenetic and Genome Research 2002, 99(1-4):17-24.
60. Rojo A., et al. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study. Acta Neuropathologica 2006, 111(6):610-616.
61. Santorelli F.M., et al. Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). American Journal of Human Genetics 1996, 58(5):933-939.
62. Schaller A., et al. Impairment of mitochondrial tRNA(Ile) processing by a novel mutation associated with chronic progressive external ophthalmoplegia. Mitochondrion 2011, 11(3):488-496.
63. Schubeler D., et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes & Development 2004, 18(11):1263-1271.
64. Schultz A.B., Chen C.Y., Edington D.W. The cost and impact of health conditions on presenteeism to employers: a review of the literature. PharmacoEconomics 2009, 27(5):365-378.
65. Shtilbans A., et al. G8363A mutation in the mitochondrial DNA transfer ribonucleic acid(Lys) gene: another cause of Leigh syndrome. Journal of Child Neurology 2000, 15(11):759-761.
66. Silvestri G., et al. A new mtDNA mutation in the trans RNALys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). American Journal of Human Genetics 1992, 51(6):1213-1217.
67. Sorm F., et al. 5-Azacytidine, a new, highly effective cancerostatic. Experientia 1964, 20(4):202-203.
68. Sparaco M., et al. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2006, 26(4):361-372.
69. Sternberg D., et al. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain: A Journal of Neurology 2001, 124:984-994.
70. Stuart S., Griffiths L.R. A possible role for mitochondrial dysfunction in migraine. Molecular Genetics and Genomics 2012, 287(11-12):837-844.
71. Sun H., Kennedy P.J., Nestler E.J. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 2013, 38(1):124-137.
72. Takai D., Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(6):3740-3745.
73. Tanji K., et al. Neuropathological features of mitochondrial disorders. Seminars in Cell & Developmental Biology 2001, 12(6):429-439.
74. Taylor R.W., et al. A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. Biochemical and Biophysical Research Communications 1998, 243(1):47-51.
75. Taylor S.W., et al. Characterization of the human heart mitochondrial proteome. Nature Biotechnology 2003, 21(3):281-286.
76. Tulinius M., et al. Leigh syndrome with cytochrome-c oxidase deficiency and a single T insertion nt 5537 in the mitochondrial tRNA(Trp) gene. Neuropediatrics 2003, 34(2):87-91.
77. Ulrich V., et al. The inheritance of migraine with aura estimated by means of structural equation modelling. Journal of Medical Genetics 1999, 36(3):225-227.
78. Uziel G., et al. Neuromuscular syndrome associated with the 3291T→C mutation of mitochondrial DNA: a second case. Neuromuscular Disorders 2000, 10(6):415-418.
79. Visscher P.M., et al. Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings. PLoS Genetics 2006, 2(3):316-325.
80. Vives-Bauza C., et al. Genotype-phenotype correlation in the 5703G>A mutation in the tRNA(Asn) gene of mitochondrial DNA. Journal of Inherited Metabolic Disease 2003, 26(5):507-508.
81. Wessman M., et al. Migraine: a complex genetic disorder. Lancet Neurology 2007, 6(6):521-532.
82. Willingham A.T., Gingeras T.R. TUF love for "junk" DNA. Cell 2006, 125(7):1215-1220.
83. Wong L.J., Boles R.G. Mitochondrial DNA analysis in clinical laboratory diagnostics. Clinica Chimica Acta; International Journal of Clinical Chemistry 2005, 354(1-2):1-20.
84. Zhao H., et al. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. American Journal of Human Genetics 2004, 74(1):139-152.